Patient Advocacy Resources

Summit Series on Cancer Clinical Trials

The need for a Summit Series is clear. Cancer clinical trials are the key to delivering quality cancer care and offering benefits to patients and those at risk. Their role in developing new and improved detection and treatment options is paramount, as they minimize geographic and institutional variations in practice patterns and represent the only scientifically valid manner in which to establish cancer treatment efficacy. In addition, external peer-review and audit functions in organized cancer research provide unparalleled degrees of institutional quality control and treatment monitoring.

Teaching the Truth About Cancer Clinical Trials

However, along with the benefits, there are public concerns surrounding cancer clinical trials that pose a threat to their continued existence. In response to these concerns, the Summit was originally convened and continues to meet, developing well-planned and practical solutions to better the current system.

The purpose of the Summit Series on Cancer Clinical Trials is to provide a platform for all stakeholders in the clinical cancer research enterprise to come together to express their concerns and devise solutions for the continued improvement of cancer clinical trials. The hope is that by building a more responsive and efficient system, trial enrollment will increase, which will permit faster development of advances in cancer treatment, prevention, control, and symptom management.

For more information on the Summit Series on Cancer Clinical Trials or to participate in the upcoming Summit go to http://www.cancersummit.org